| Global epidemiology of injecting drug use and HIV among people who inject drugs: a systematic review BM Mathers, L Degenhardt, B Phillips, L Wiessing, M Hickman, ... The Lancet 372 (9651), 1733-1745, 2008 | 1576 | 2008 |
| Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies L Sordo, G Barrio, MJ Bravo, BI Indave, L Degenhardt, L Wiessing, M Ferri, ... bmj 357, 2017 | 1104 | 2017 |
| HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage BM Mathers, L Degenhardt, H Ali, L Wiessing, M Hickman, RP Mattick, ... Lancet 375 (9719), 1014-1028, 2010 | 860* | 2010 |
| Mortality among people who inject drugs: a systematic review and meta-analysis BM Mathers, L Degenhardt, C Bucello, J Lemon, L Wiessing, M Hickman Bulletin of the World Health Organization 91, 102-123, 2013 | 458 | 2013 |
| The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference A Hatzakis, S Wait, J Bruix, M Buti, M Carballo, M Cavaleri, M Colombo, ... Journal of viral hepatitis 18, 1-16, 2011 | 335 | 2011 |
| Infection with hepatitis B and C virus in Europe: a systematic review of prevalence and cost-effectiveness of screening SJM Hahné, IK Veldhuijzen, L Wiessing, TA Lim, M Salminen, M Laar BMC infectious diseases 13 (1), 1-16, 2013 | 273 | 2013 |
| Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention L Wiessing, M Ferri, B Grady, M Kantzanou, I Sperle, KJ Cullen, ... PloS one 9 (7), e103345, 2014 | 243 | 2014 |
| Meth/amphetamine use and associated HIV: Implications for global policy and public health L Degenhardt, B Mathers, M Guarinieri, S Panda, B Phillips, SA Strathdee, ... International Journal of Drug Policy 21 (5), 347-358, 2010 | 179 | 2010 |
| Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners A Kamarulzaman, SE Reid, A Schwitters, L Wiessing, N El-Bassel, ... The Lancet 388 (10049), 1115-1126, 2016 | 176 | 2016 |
| Estimates of injecting drug users at the national and local level in developing and transitional countries, and gender and age distribution C Aceijas, SR Friedman, HLF Cooper, L Wiessing, GV Stimson, ... Sexually transmitted infections 82 (suppl 3), iii10-iii17, 2006 | 165 | 2006 |
| Estimating prevalence of problem drug use at national level in countries of the European Union and Norway L Kraus, R Augustin, M Frischer, P Kümmler, A Uhl, L Wiessing Addiction 98 (4), 471-485, 2003 | 164 | 2003 |
| What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews L Degenhardt, C Bucello, B Calabria, P Nelson, A Roberts, W Hall, ... Drug and alcohol dependence 117 (2-3), 85-101, 2011 | 152 | 2011 |
| Monitoring hepatitis C virus infection among injecting drug users in the European Union: a review of the literature K Roy, G Hay, R Andragetti, A Taylor, D Goldberg, L Wiessing Epidemiology & Infection 129 (3), 577-585, 2002 | 147 | 2002 |
| The Dutch famine birth cohort study: design, validation of exposure, and selected characteristics of subjects after 43 years follow‐up LH Lumey, ACJ Ravelli, LG Wiessing, JG Koppe, PE Treffers, ZA Stein Paediatric and perinatal epidemiology 7 (4), 354-367, 1993 | 147 | 1993 |
| Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study D Paraskevis, G Nikolopoulos, A Fotiou, C Tsiara, D Paraskeva, V Sypsa, ... PloS one 8 (11), e78941, 2013 | 130 | 2013 |
| A comparison of different methods for estimating the prevalence of problematic drug misuse in Great Britain M Frischer, M Hickman, L Kraus, F Mariani, L Wiessing Addiction 96 (10), 1465-1476, 2001 | 125 | 2001 |
| Modelling the spread of HIV in social networks of injecting drug users M Kretzschmar, LG Wiessing Aids 12 (7), 801-811, 1998 | 110 | 1998 |
| The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference A Hatzakis, P Van Damme, K Alcorn, C Gore, M Benazzouz, S Berkane, ... Journal of viral hepatitis 20, 1-20, 2013 | 96 | 2013 |
| Can hepatitis C virus prevalence be used as a measure of injection‐related human immunodeficiency virus risk in populations of injecting drug users? An ecological analysis P Vickerman, M Hickman, M May, M Kretzschmar, L Wiessing Addiction 105 (2), 311-318, 2010 | 91 | 2010 |
| Guidelines for the treatment of hepatitis C virus infection in injection drug users: status quo in the European Union countries J Reimer, B Schulte, X Castells, I Schafer, S Polywka, D Hedrich, ... Clinical infectious diseases 40 (Supplement_5), S373-S378, 2005 | 74 | 2005 |
M HickmanVerified email at bristol.ac.uk
